Curated News: National Heart, Lung, and Blood Institute (NHLBI)

Filters close
10-May-2021 10:35 AM EDT
Researchers Discover New Genetic Variants Responsible for Neurodevelopmental Disorders
Children's Hospital of Philadelphia

Researchers have revealed how variants of a gene responsible for packing and condensing genetic material present a novel cause for certain neurodevelopmental disorders.

Released: 10-May-2021 11:10 AM EDT
Older adults are having abdominal surgery less frequently — but it depends on the surgery and the hospital
University of Chicago Medical Center

Contrary to popular belief, a new study from the University of Chicago Medicine found the frequency of abdominal surgery in older adults is decreasing, especially among adults over the age of 85.

Released: 4-May-2021 12:30 PM EDT
Researchers identify potential combination therapy for aggressive lung cancer
University of California, Los Angeles (UCLA), Health Sciences

The combination approach uses immune checkpoint inhibitors with ATRA, a safe medication that is widely used to treat leukemia.

Released: 27-Apr-2021 8:30 AM EDT
A new treatment that might keep COVID-19 patients off the ventilator
Ohio State University

A new treatment is among the first known to reduce the severity of acute respiratory distress syndrome caused by the flu in animals, according to a new study.

Released: 26-Apr-2021 9:00 AM EDT
Anemia Discovery Points to More Effective Treatment Approaches
University of Virginia Health System

A combination of inexpensive oral medications may be able to treat fatigue-inducing anemias caused by chronic diseases and inflammation, a new discovery from the University of Virginia School of Medicine suggests.

13-Apr-2021 9:00 AM EDT
Norovirus Clusters are Resistant to Environmental Stresses and UV Disinfection, New Study Finds
George Washington University

Clusters of a virus known to cause stomach flu are resistant to detergent and ultraviolet disinfection, according to new research co-led by Danmeng Shuai, Ph.D., an associate professor of civil and environmental engineering at the George Washington University and Nihal Altan-Bonnet, Ph.D., a senior investigator and the head of the Laboratory of Host-Pathogen Dynamics at the National Heart, Lung, and Blood Institute, part of the National Institutes of Health.

   
Released: 13-Apr-2021 11:00 AM EDT
Amoeba Biology Reveals Potential Treatment Target for Lung Disease
Johns Hopkins Medicine

In a series of experiments that began with amoebas — single-celled organisms that extend podlike appendages to move around — Johns Hopkins Medicine scientists say they have identified a genetic pathway that could be activated to help sweep out mucus from the lungs of people with chronic obstructive pulmonary disease a widespread lung ailment.

16-Mar-2021 12:20 PM EDT
Genetic testing proves beneficial in prescribing effective blood thinners
Mayo Clinic

A new research paper funded in part by the National Heart, Lung and Blood Institute (NHLBI) shows a clear advantage of genetic testing in helping health care providers choose the appropriate anti-platelet drug. Testing helps determine if a patient carries genetic variants in CYP2C19 that cause loss of its function. These variants interfere with the body's ability to metabolize and activate clopidogrel, an anti-platelet medication.

Released: 15-Mar-2021 12:55 PM EDT
Black Women More Likely To Gain Weight Than White Women After Menopause
RUSH

In a study published published in the medical journal PLOS ONE, researchers from Rush Institute for Health Aging find that racial disparities play a role in weight gain in older women.

Released: 11-Mar-2021 9:40 AM EST
Electricity could help speed wound healing, new study shows
Ohio State University

Electric stimulation may be able to help blood vessels carry white blood cells and oxygen to wounds, speeding healing, a new study suggests.

Released: 9-Mar-2021 12:25 PM EST
Immune cell implicated in development of lung disease following viral infection
Washington University in St. Louis

Scientists at Washington University School of Medicine in St. Louis have implicated a type of immune cell in the development of chronic lung disease that sometimes is triggered following a respiratory viral infection. The evidence suggests that activation of this immune cell serves as an early switch that, when activated, drives progressive lung diseases, including asthma and chronic obstructive pulmonary disease (COPD).

Released: 25-Feb-2021 7:30 PM EST
Diversity Among Study Participants Credited with Identifying Gene Linked to Asthma
Henry Ford Health

Researchers at Henry Ford Health System, as part of a national asthma collaborative, have identified a gene variant associated with childhood asthma that underscores the importance of including diverse patient populations in research studies. The study is published in the print version of the American Journal of Respiratory and Critical Care Medicine.

Released: 24-Feb-2021 11:45 AM EST
Losing Obamacare protections during pandemic could increase health disparities
Oregon Health & Science University

If Affordable Care Act protections for pre-existing condition coverage are no longer available, the coronavirus pandemic would leave many Americans - a disproportionate number of whom are people of color - without health insurance, a new Oregon Health & Science University study indicates.

   
23-Feb-2021 11:30 AM EST
Researchers Identify Mechanism By Which Exercise Strengthens Bones And Immunity
UT Southwestern Medical Center

Scientists at the Children’s Medical Center Research Institute at UT Southwestern (CRI) have identified the specialized environment, known as a niche, in the bone marrow where new bone and immune cells are produced. The study, published in Nature, also shows that movement-induced stimulation is required for the maintenance of this niche, as well as the bone and immune-forming cells that it contains. Together, these findings identify a new way that exercise strengthens bones and immune function.

Released: 23-Feb-2021 4:35 PM EST
You’ve Got to Move It, Move It
UC San Diego Health

Research from Herbert Wertheim School of Public Health and Human Longevity Science at UC San Diego suggests that light-intensity physical activity, including shopping or a casual walk, may protect against mobility disability in older women.

Released: 23-Feb-2021 2:30 PM EST
New strategy blocks chronic lung disease in mice
Washington University in St. Louis

A new study from Washington University School of Medicine in St. Louis has uncovered a previously unknown role for exosomes in inflammatory respiratory diseases. The study has implications for finding new therapies. Exosomes are tiny compartments released from cells that carry different types of cargo, including inflammatory chemicals called cytokines that can drive lung disease.

Released: 11-Feb-2021 2:05 PM EST
Move quickly to relax
Wayne State University Division of Research

A team of Wayne State University School of Medicine researchers led by Charles Chung, Ph.D., assistant professor of physiology, recently received a $1,894,271 grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health to address the critical need for new drug targets and diagnostic indexes for diastolic dysfunction using novel biomechanical tests that ultimately can be translated into clinical practice.

Released: 11-Feb-2021 12:10 PM EST
Heart Health Problems in Your 20s May Affect Brain Health Decades Later
American Academy of Neurology (AAN)

Having health issues such as smoking, high cholesterol or a high body mass index (BMI) in your 20s may make you more likely to have problems with thinking and memory skills and even the brain’s ability to properly regulate its blood flow, according to a preliminary study released today that will be presented at the American Academy of Neurology's 72nd Annual Meeting in Toronto, Canada, April 25 to May 1, 2020.

Released: 12-Jan-2021 11:00 AM EST
Spikes in cardiovascular deaths shown to be an indirect cost of COVID-19 pandemic
Beth Israel Deaconess Medical Center

In a new study from Beth Israel Deaconess Medical Center (BIDMC), researchers analyzed data from the National Center for Health Statistics to compare the rate of cardiovascular-related deaths before and after the onset of the pandemic in the United States, relative to the same periods in the prior year.

1-Dec-2020 11:20 AM EST
Synthetic Biology and Machine Learning Speed the Creation of Lab-Grown Livers
Health Sciences at the University of Pittsburgh

Researchers at the University of Pittsburgh School of Medicine have combined synthetic biology with a machine learning algorithm to create human liver organoids with blood and bile handling systems. When implanted into mice with failing livers, the lab-grown replacement livers extended life.

   
3-Dec-2020 8:10 AM EST
New updates to federal guidelines revamp asthma management
University of Chicago Medical Center

The National Institutes of Health today announced 19 recommendations in six key areas of asthma diagnosis, management and treatment.

Released: 23-Nov-2020 12:15 PM EST
Scientists Identify Brain Cells that Help Drive Bodily Reaction to Fear, Anxiety
University of North Carolina School of Medicine

This research helps illuminate the neural roots of emotions, and points to the possibility that a population of arousal-related neurons might be a target of future treatments for anxiety disorders and other illnesses involving abnormal arousal responses.

   
Released: 9-Nov-2020 4:00 PM EST
All Weight Loss Isn’t Equal For Reducing Heart Failure Risk
UT Southwestern Medical Center

DALLAS – Nov. 9, 2020 – Reducing the level of body fat and waist size are linked to a lower risk of heart failure in patients with type 2 diabetes, a study led by UT Southwestern researchers indicates. The findings, reported today in Circulation, suggest that all weight loss isn’t equal when it comes to mitigating the risk of heart disease.

9-Nov-2020 9:55 AM EST
Hydroxychloroquine Does Not Help Patients Hospitalized with COVID-19: Study
Vanderbilt University Medical Center

Findings from a national study published today in the Journal of the American Medical Association (JAMA) “do not support” the use of hydroxychloroquine for the treatment of adult patients hospitalized with COVID-19.

Released: 28-Oct-2020 8:00 AM EDT
Study Documents Racial Differences In U.S. Hospice Use And End-Of-Life Care Preferences
Johns Hopkins Medicine

In a new medical records analysis of racial disparities in end-of-life care, researchers at Johns Hopkins Medicine and three collaborating institutions report that Black patients voluntarily seek substantially more intensive treatment, such as mechanical ventilation, gastronomy tube insertion, hemodialysis, CPR and multiple emergency room visits in the last six months of life, while white patients more often choose hospice services.

Released: 21-Oct-2020 2:10 PM EDT
Rogel team receives $11.2M to leverage the microbiome against GVHD
Michigan Medicine - University of Michigan

A team of researchers from the Rogel Cancer Center received an $11.2 million grant from the National Heart, Lung and Blood Institute to study how to use the microbiome to limit complications of stem cell transplants for blood cancers and other diseases.

Released: 13-Oct-2020 11:15 AM EDT
Rensselaer, GE Research, Cleerly, and Cornell Partner With NIH To Improve Cardiac CT Diagnosis
Rensselaer Polytechnic Institute (RPI)

With the support of a $3.7 million grant from the National Institutes of Health’s (NIH) National Heart, Lung, and Blood Institute, an academic-industrial collaboration between General Electric Research, Rensselaer Polytechnic Institute, Cleerly, and Weill Cornell Medicine will develop cutting-edge techniques for removing the appearance of blurry images — known as blooming artifacts — from cardiac CT scans to improve the accuracy of cardiac diagnosis and prevent patients from having to undergo costly and invasive procedures.

   
Released: 8-Oct-2020 8:00 AM EDT
Blocking Immune System Pathway May Stop COVID-19 Infection, Prevent Severe Organ Damage
Johns Hopkins Medicine

While the world waits eagerly for a safe and effective vaccine to prevent infections from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus behind the COVID-19 pandemic, researchers also are focusing on better understanding how SARS-CoV-2 attacks the body in the search for other means of stopping its devastating impact. The key to one possibility — blocking a protein that enables the virus to turn the immune system against healthy cells — has been identified in a recent study by a team of Johns Hopkins Medicine researchers.

9-Sep-2020 11:05 AM EDT
Study shows high blood pressure awareness and control are declining in America
University of Alabama at Birmingham

After nearly 15 years on an upward trend, awareness among Americans about their high blood pressure and rates of blood pressure control are now on the decline. many groups, including older adults and Black adults, are less likely than they were in earlier years to control their blood pressure.

Released: 2-Sep-2020 11:05 AM EDT
Study leads to better understanding of blood pressure regulation, atherosclerosis
University of Kentucky

A new University of Kentucky College of Medicine study provides insight into how a protein called angiotensinogen contributes to blood pressure regulation and atherosclerosis.

Released: 27-Aug-2020 3:50 PM EDT
Estrogen May Lessen Severity of COVID-19 Symptoms in Women, Study Says
Atrium Health Wake Forest Baptist

Why are men at greater risk than women for more severe symptoms and worse outcomes from COVID-19 regardless of age?

20-Aug-2020 6:30 PM EDT
Compared to Placebo, Vitamin D Has No Benefit for Severe Asthma Attacks
Health Sciences at the University of Pittsburgh

Contrary to earlier observational results, vitamin D supplements do not prevent severe asthma attacks in at-risk children, according to the first placebo-controlled clinical trial to test this relationship.

Released: 18-Aug-2020 9:00 AM EDT
Scan For Arterial Plaque is Better At Predicting Heart Attack Than Stroke
UT Southwestern Medical Center

DALLAS – Aug. 18, 2020 – The amount of calcified plaque in the heart’s arteries is a better predictor of future heart attacks than of strokes, with similar findings across sex and racial groups, according to new research from UT Southwestern.

Released: 14-Aug-2020 11:55 AM EDT
Convalescent Plasma Associated with Reduced COVID-19 Mortality in 35,000-Plus Hospitalized Patients
Mayo Clinic

Mayo Clinic and collaborators have published a preprint that identifies two main signals of efficacy that can inform future clinical trials on plasma therapy on COVID-19 patients. The data are extracted from the Mayo-led national Expanded Access Program (EAP) for convalescent plasma for the treatment of hospitalized patients with COVID-19.

Released: 12-Aug-2020 2:00 PM EDT
“Reelin” In A New Treatment For Multiple Sclerosis
UT Southwestern Medical Center

DALLAS – Aug. 12, 2020 – In an animal model of multiple sclerosis (MS), decreasing the amount of a protein made in the liver significantly protected against development of the disease’s characteristic symptoms and promoted recovery in symptomatic animals, UTSW scientists report.

Released: 3-Aug-2020 8:55 AM EDT
American College of Radiology to Provide Image Coordination for National COVID-19 Observational Study
American College of Radiology (ACR)

The American College of Radiology® (ACR®) Center for Research and Innovation™ (CRI) will serve as the imaging coordination center for the multicenter COVID-19 Observational Study (CORAL) led by Dr. Catherine "Terri" L. Hough of the Oregon Health & Science University. The CORAL Study is part of the Prevention & Early Treatment of Acute Lung Injury (PETAL) Network, a consortium of academic and affiliated hospitals across the United States – funded by the National Heart, Lung, and Blood Institute, part of the National Institutes of Health – to conduct clinical trials in patients with or at risk for critical illness, including acute respiratory distress syndrome.

Released: 29-Jul-2020 10:00 AM EDT
Cholesterol-Lowering Drug Improved Function of Heart's Arteries
Johns Hopkins Medicine

In a pilot study of people living with HIV or high levels of cholesterol, Johns Hopkins Medicine researchers found that a six-week course of a cholesterol-lowering medication improved the function of the coronary arteries that provide oxygen to the heart.

Released: 28-Jul-2020 10:45 AM EDT
Higher BPA Levels Linked to More Asthma Symptoms in Children
Johns Hopkins Bloomberg School of Public Health

Children in low-income neighborhoods in Baltimore tended to have more asthma symptoms when levels of the synthetic chemical BPA (Bisphenol A) in their urine were elevated, according to a study from researchers at the Johns Hopkins Bloomberg School of Public Health and School of Medicine.

22-Jul-2020 8:05 PM EDT
T cells can shift from helping to harming in atherosclerosis
La Jolla Institute for Immunology

At La Jolla Institute for Immunology (LJI) researchers are dedicated to finding a way to stop plaques from forming in the first place. In a new study, LJI scientists show that certain T lymphocytes, a type of white blood cell, that start out trying to fight the disease can end up increasing inflammation and making atherosclerosis cases even worse.

Released: 17-Jul-2020 12:40 PM EDT
Cannabis shows potential for mitigating sickle cell disease pain
University of California, Irvine

Cannabis appears to be a safe and potentially effective treatment for the chronic pain that afflicts people with sickle cell disease, according to a new clinical trial co-led by University of California, Irvine researcher Kalpna Gupta and Dr. Donald Abrams of UC San Francisco. The findings appear in JAMA Network Open.

Released: 15-Jul-2020 4:25 PM EDT
New antiplatelet drug shows promise for treating heart attack
University of Illinois Chicago

Researchers have developed a new drug that prevents blood clots without causing an increased risk of bleeding, a common side effect of all antiplatelet medications currently available. A new study published in the journal Science Translational Medicine describes the drug and its delivery mechanisms and shows that the drug is also an effective treatment for heart attack in animal models.

Released: 15-Jul-2020 12:35 PM EDT
Researchers 3D print a working heart pump with real human cells
University of Minnesota College of Science and Engineering

In a groundbreaking new study, researchers at the University of Minnesota have 3D printed a functioning centimeter-scale human heart pump in the lab. The discovery could have major implications for studying heart disease, the leading cause of death in the United States killing more than 600,000 people a year.

Released: 14-Jul-2020 11:45 AM EDT
Umbilical Cord Blood Successfully Treats Rare Genetic Disorders in Largest Study to Date
Health Sciences at the University of Pittsburgh

Infusing umbilical cord blood – a readily available source of stem cells – safely and effectively treated 44 children born with various non-cancerous genetic disorders, including sickle cell, thalassemia, Hunter syndrome, Krabbe disease, MLD, and an array of immune deficiencies.

Released: 22-Jun-2020 9:55 AM EDT
Major US Trial Closes Showing No Benefit for Hydroxychloroquine in COVID-19
Vanderbilt University Medical Center

The Outcomes Related to COVID-19 Treated with Hydroxychloroquine among In-patients with Symptomatic Disease (ORCHID) trial stopped enrolling new patients based on the fourth scheduled interim analysis showing no evidence of benefit or harm.

Released: 18-Jun-2020 1:05 PM EDT
Homeless Patients Are More Likely to be Readmitted to a Hospital Within 30 Days of Discharge
Perelman School of Medicine at the University of Pennsylvania

Patients who are homeless are far more likely than housed individuals to be readmitted to a hospital within 30 or 90 days of their discharge, according to a new multi-center analysis of inpatient data from Florida, Massachusetts and New York.

4-May-2020 5:10 PM EDT
NIH Statement on World Asthma Day 2020
National Institute of Environmental Health Sciences (NIEHS)

Today on World Asthma Day, the National Institutes of Health stands with patients, families, advocates, researchers, and health care professionals to raise awareness about this common chronic respiratory disease, the people it affects, and the research that improves its prevention and treatment.

Released: 29-Apr-2020 12:30 PM EDT
Trial of Highly Touted Drug Begins at Montefiore and Einstein
Albert Einstein College of Medicine

Researchers at Montefiore Health System and Albert Einstein College of Medicine have begun testing the drug hydroxychloroquine for the treatment of COVID-19, as part of a nationwide trial sponsored by the National Heart, Lung, and Blood Institute (NHLBI).

   
Released: 29-Apr-2020 9:00 AM EDT
New University of Kentucky study could change what we know about platelets
University of Kentucky

The $6.6 million study will focus on how platelets function when they form clots in blood vessels and when they sense circulating pathogens, like viruses.

17-Apr-2020 4:55 PM EDT
Pulse Oximetry Monitoring Overused in Infants with Bronchiolitis
Children's Hospital of Philadelphia

Monitoring blood oxygen levels with continuous pulse oximetry is being overused in infants with bronchiolitis who do not require supplemental oxygen, according to a study by researchers at Children’s Hospital of Philadelphia (CHOP). The researchers found the use of continuous pulse oximetry occurred frequently and varied widely among hospitals in their sample, despite national recommendations advising against the practice.

Released: 2-Apr-2020 3:35 PM EDT
Reaching toward a cure for sickle cell disease
Case Western Reserve University

The National Heart, Lung, and Blood Institute (NHLBI) has awarded Case Western Reserve University up to $3.7 million to assess emerging genome-editing based therapies being tested for curing sickle cell disease (SCD) at leading U.S research universities and hospitals. SCD is the most well-known among a group of inherited blood disorders, affecting about 100,000 people in the United States and about 20 million worldwide, according to a 2018 National Institutes of Health (NIH) statement announcing the NHLBI Cure Sickle Cell Initiative.


Showing results 101–150 of 174


close
1.43191